Sun Pharmaceuticals
Sun Pharma buyout of Ranbaxy gets conditional US nod
31 Jan 2015
Fearing that the $4-billion deal would be anti-competitive, the FTC has stipulated that Sun sell its interest in a generic anti-bacterial medicine
Sun Pharma, Ranbaxy merger deal gets conditional CCI nod
09 Dec 2014
The CCI has asked the two companies to sell off seven brands with combined sales of less than Rs50 crore and market share of 60 to 80 per cent, which the regulator felt, would adversely affect competition
Sun-Ranbaxy merger: competition panel demands more details
28 Aug 2014
This is probably the first instance where the fair trade watchdog has ordered a public scrutiny of a proposed merger and acquisition deal to ensure compliance to fair trade regulation
AP High Court vacates stay on Ranbaxy-Sun Pharma merger
24 May 2014
The Andhra Pradesh High Court has vacated a stay on the proposed merger of Ranbaxy Laboratories with Sun Pharma over alleged insider trading in Ranbaxy shares ahead of the merger announcement
